Innovator’s Pitch Challenge

Vote for Me

Interested in Connecting? Please contact:
Dr. Aurélien Rizk
CEO
rizk@interaxbiotech.com

Message the company or request a 1:1 meeting here

InterAx Biotech AG, headquartered in Switzerland, has developed a unique drug discovery platform to reduce the time and costs associated with the discovery and development of new drugs for a wide array of human diseases. Our technology combines in-vitro laboratory experiments with mathematical modeling of cellular reactions and machine learning to discover new effective treatments and de-risk clinical trials.

Partnerships with two leading pharmaceutical companies, Boehringer Ingelheim and Lundbeck, and one biotech company, GPCR Therapeutics, allowed us to validate our approach. InterAx is currently applying its technology to an in-house drug discovery program in the field of oncology and has discovered a new molecular entity targeting a solid tumor with high unmet needs.

Pitch Video

Slide Deck